Delta4

Delta4 in the Spotlight

Latest News & Events

Five people gather around a desk, focusing on a computer screen. One person is seated and using the mouse, while the others stand behind observing. Indoor setting with natural light from large windows.

Biomedical Knowledge Graphs for Drug Discovery: Delta4’s Innovative Approach

The term “knowledge graph” describes the process of storing data in a graph-structured topology. A graph database consists of three ...
Read More
A doctor holding up a tablet with an image of a kidney.

Pioneering the Future of Nephrotic Syndrome Research with ARREST-NEPHROSIS

Nephrotic Syndrome affects millions globally, presenting a significant health burden with its hallmark symptoms of severe proteinuria and edema. The ...
Read More
group of attendees at Bio-Europe Spring

Delta4 At BIO-Europe

Delta4 at BIO-Europe 2023: Fostering Partnerships and Driving Innovation We are excited to share Delta4’s presence at the recently concluded ...
Read More
Digital Health Envision

Digital Health Envision Summit

We are delighted to announce that Dr. Klaus Kratochwill, CSO, and Dr. Paul Perco, Computational Biology Lead of Delta4, are ...
Read More
Diving deep into the realms of computational drug repurposing

Case Study: Unravelling the Multifaceted Potential of Iguratimod with Delta4’s Hyper-C Platform

Diving deep into the realms of computational drug repurposing, Delta4 leveraged its state-of-the-art Hyper-C platform with an ambitious objective: to ...
Read More
RexPo23

Delta4 at RExPO: Pushing the Boundaries of Drug Repurposing

We are thrilled to announce that Delta4 will be in attendance at this year’s RExPO23, a landmark event in the ...
Read More
Reactome

Reactome Spotlights Delta4’s Computational Drug Repositioning of Clopidogrel for FSGS

We are honored to announce that our publication on the computational drug repositioning of clopidogrel has been highlighted in the ...
Read More
Delta team

Delta4 joins the EU-funded COST action PerMediK (Personalized medicine in chronic kidney disease: improved outcome based on Big Data)

The scientific goal of PerMediK is to foster development toward personalized medicine in chronic kidney disease (CKD), based on multidimensional ...
Read More
OntoloViz

Delta4’s Innovation Shines: OntoloViz Article Published in Bioinformatics Advances Journal

We are thrilled to announce that our journal article, titled “OntoloViz: a GUI for interactive visualization of ranked disease or ...
Read More
Clopidogrel in FSGS

Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform

Delta4, a digital drug discovery company, identified a potential therapeutic option for Focal Segmental Glomerulosclerosis (FSGS) using their Hyper-C AI ...
Read More
Delta4 CEO Kurt Herpel

Delta4 CEO Kurt Herpel Featured in Insightscare Magazine: A Vision for the Future of Drug Discovery

We are incredibly proud to share that our esteemed CEO, Kurt Herpel, has recently been profiled in Insightscare Magazine. In ...
Read More
scientist reviewing data on computer

Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board

VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for ...
Read More
Kurt Herpel, CEO of Delta4, and Revital Rattenbach, CEO of 4P-Pharma, celebrating the signature of a partnership agreement between Delta4 and 4P-Pharma in Paris (France).

4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease

Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital ...
Read More
clinical trial consultation

Delta4, in preparation for the first clinical study, focused on FSGS

Focal Segmental Glomerulosclerosis (FSGS) is a devastating clinical condition with defined glomerular histopathology and yet a multifaceted pathophysiological, histological, and ...
Read More
The logo for bio europe is shown in front of a group of people.

Delta4 at BIO-EUROPE 2021

From October 25-28 Delta4 attended the (virtual) BIO-EUROPE conference, the largest partnering event in Europe dedicated to the global biotechnology ...
Read More
A hand holding a pen on a tablet in the dark.

Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board

VIENNA, Austria, September 27th, 2021 — Delta4, a digital drug discovery company focusing on the identification of new indications for ...
Read More
Two scientists in lab coats looking at a microscope.

Delta4 expands Team and tackles new indications

A Welcome to Our Newest Member Following our Financing in March 2021 and our move into new premises in July ...
Read More
office desk

Office News – July ’21

We are excited to announce that Delta4 has moved into a new office in the 8th district, close to the city ...
Read More
A calculator sits on top of a sheet of paper.

Alfred Steininger to Join Delta4 as CFO

We are very pleased to introduce Alfred Steininger as our new Chief Financial Officer, starting in mid-July 2021. Alfred brings ...
Read More
A laptop on a desk.

Press Release – April ’21

Delta4 Announces Closing of Multi-million Series A Financing Round Company to Expand Focus Beyond Renal Diseases and COVID-19 Compounds Identified ...
Read More
Photo by National Cancer Institute on unsplash.com

FSGS and COVID-19 programs ready for Phase II studies

We are proud to announce further progress in our current drug discovery and development programs. In late 2020, Delta4 filed ...
Read More
Photo by Scott Graham on unsplash.com

Delta4 files four patent applications in FSGS and COVID-19

We are very pleased to announce that Delta4 has filed four patent applications for compounds and combinations of compounds in ...
Read More
A red and white logo with a red background.

BIO-Europe 2020 Digital – Partnering Event

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to ...
Read More
Sachs 20th Annual Biotech

Sachs 20th Annual Biotech In Europe Forum

The 20th Annual Biotech in Europe (BEF) Forum is recognized as the leading international Stage for those interested in investing ...
Read More
The world orphan drug logo.

World Orphan Drug Congress

With over 1,500 attendees from 50+ countries, the 2020 edition of the World Orphan Drug Congress USA was held online ...
Read More
A laptop on a desk.

Press Release – June 2020

Delta4 Announces Results Achieved with Drug Discovery Platform Vienna, Europe (June 2, 2020) – Delta4, a biotech company using its ...
Read More
An image of a coronavirus on a white background.

COVID-19 – Call to Action

The global crisis caused by the SARS-Cov2 outbreak requires rapidly applicable therapeutics. Available approved drug substances represent one of the ...
Read More
A poster with the words discover cure january-february 2020 in san francisco.

Biotech Showcase 2020 @JPM San Francisco

What Is It? Biotech Showcase™ is an investor conference during JPM 2020, devoted to providing private and public biotech companies ...
Read More
LSX Investival Showcase

LSX Investival

Delta4 Reflects on the 2020 LSX Investival Showcase: A Landmark Event in Life Sciences Innovation In November 2020, the prestigious ...
Read More
Life-Science Investment Days, Vienna

Life-Science Investment Days, Vienna

Delta4 Attends the Life Science Investment Days Event of 2019 The Life Science Investment Days event held in Vienna from ...
Read More
Biotech in Europe Forum (BEF)

Biotech in Europe Forum (BEF)

Delta4’s Participation at the 19th Annual Biotech in Europe Forum: A Landmark Experience Delta4 was honored to attend the 19th ...
Read More